Our investigation delves into the impact of G-CSF on HCC and its underlying molecular framework through the lens of Tumor-Associated Macrophages (TAM), thereby illuminating novel therapeutic approaches and objectives for the clinical management of hepatocellular carcinoma. This evidence concerns the gene CSF3 and neoplasm.